GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Won Tech Co 336570.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

3,460

-1.00%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩156.84bn

FY2019FY2025

Net income

₩35.22bn

FY2019FY2025

Free cash flow

₩49.82bn

FY2019FY2025

Shareholders' equity

₩157.38bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₩156.84bn₩115.25bn₩115.63bn₩81.51bn₩51.06bn——
Gross profit₩105.79bn₩74.14bn₩74.26bn₩48.81bn₩28.93bn——
Research and development₩1.89bn₩1.72bn₩967.6m₩570.8m₩888.1m——
Operating income₩51.69bn₩34.68bn₩45.93bn₩26.76bn−₩90.2m−₩47.1m−₩27.1m
Net income₩35.22bn₩29.11bn₩38.83bn₩13.40bn−₩36.1m₩41.3m−₩31.4m
Diluted earnings per share391.50325.88440.43152.36-6.437.37-5.59

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₩217.25bn₩177.90bn₩153.27bn₩73.79bn₩11.40bn₩11.40bn₩11.32bn
Cash and short-term investments—₩88.51bn₩80.96bn₩30.37bn₩11.38bn₩1.27bn₩1.31bn
Total liabilities₩59.87bn₩51.11bn₩53.99bn₩16.73bn₩777.9m₩737.5m₩698.5m
Debt₩191.1m₩28.73bn₩30.05bn₩5.33bn₩741.0m₩691.0m₩645.0m
Shareholders' equity₩157.38bn₩126.80bn₩99.28bn₩57.06bn₩10.62bn₩10.66bn₩10.62bn
Shares outstanding90m89m88m88m6m6m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₩51.14bn₩14.93bn₩25.96bn₩14.78bn₩6.09bn−₩48.6m−₩73.9m
Capital spending−₩1.32bn−₩1.96bn−₩3.17bn−₩543.2m−₩510.2m——
Free cash flow₩49.82bn₩12.96bn₩22.78bn₩14.24bn₩5.58bn−₩48.6m−₩73.9m
Dividends paid−₩4.45bn−₩4.39bn—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩47.49bn₩40.25bn₩46.37bn₩33.24bn₩39.81bn₩37.42bn₩36.79bn₩26.88bn
Gross profit₩29.88bn₩28.61bn₩31.12bn₩22.63bn₩28.02bn₩24.02bn₩23.32bn₩17.25bn
Operating income₩25.35bn₩11.20bn₩12.25bn₩7.61bn₩17.27bn₩14.55bn₩13.79bn₩7.34bn
Net income₩15.45bn₩10.42bn₩6.23bn₩7.89bn₩9.20bn₩11.92bn₩13.95bn₩4.81bn
Diluted earnings per share174.08116.7869.8387.69102.29133.38156.1953.86
Cash from operations—−₩7.46bn₩19.12bn₩10.62bn₩8.07bn₩13.32bn₩13.31bn₩7.10bn
Capital spending—−₩510.0m−₩544.0m−₩340.0m−₩217.0m−₩219.0m−₩330.0m−₩257.0m
Free cash flow—−₩7.97bn₩18.58bn₩10.28bn₩7.85bn₩13.11bn₩12.98bn₩6.84bn
Total assets₩278.76bn₩227.28bn₩217.25bn₩214.52bn₩200.41bn₩190.48bn₩177.90bn₩164.06bn
Cash and short-term investments—————₩101.42bn₩88.51bn₩76.59bn
Debt₩31.24bn₩200.3m₩191.1m₩188.1m₩183.0m₩924.1m₩1.15bn₩588.2m
Shareholders' equity₩173.02bn₩163.41bn₩157.38bn₩156.87bn₩148.85bn₩134.29bn₩126.80bn₩113.45bn

Financial ratios

Data as of 31 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin67.5%64.3%64.2%59.9%56.7%—
Operating margin33.0%30.1%39.7%32.8%-0.2%—
Net margin22.5%25.3%33.6%16.4%-0.1%—
Return on equity22.4%23.0%39.1%23.5%-0.3%0.4%
Return on assets16.2%16.4%25.3%18.2%-0.3%0.4%
Revenue growth36.1%-0.3%41.9%59.6%——
Earnings growth21.0%-25.0%189.9%-37250.3%-187.3%-231.8%
Current ratio3.09x3.26x2.63x5.41x1.98x885.29x
Debt to equity0.00x0.00x0.00x0.08x0.07x0.06x
Equity ratio72.4%71.3%64.8%77.3%93.2%93.5%
Interest coverage21.53x15.13x67.10x87.09x-1.85x-1.02x
R&D as a share of sales1.2%1.5%0.8%0.7%1.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue24.4%——
Operating income24.5%——
Net income38.0%285.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin66.1%64.6%——
Operating margin31.7%33.9%——
Net margin23.6%24.8%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings19.813.521.230.5-416.2284.4
Price to sales4.53.47.15.00.3—

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 28 Mar 2025.

FY2025FY2024
Paid in the year50.0050.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.